• Development of fluorine-18-labeled deoxyglucose, the most widely used tracer for studies of the brain and the management of cancer and other diseases.
  • First application of PET to study drug abuse.
  • Development of novel addiction treatment based on preclinical and clinical research.
  • Discovery of pleasure/ reward circuit deficiencies in obesity.
  • Discovery of cigarettes' effects on brain neurochemistry, leading to a new approach to smoking cessations.

 

 

Top of Page

Last Modified: March 11, 2008